The reason is that a meta-analysis of the degludec major trials showed a potential adverse CV signal.

FORBES: FDA Panel Backs New Diabetes Drug: Will CV Study Be Needed Before Approval?

One reason: a 17, 000-patient analysis from Sweden that shows an increased risk of death.

FORBES: Stents, Smoke And Fire

Another reason I like retracement analysis is that you are able to develop several well-defined potential profit levels.

FORBES: Finding High-Probability Entry Levels

The reason is that if this analysis is internally consistent then we ought to be able to add layer-by-layer on to it until we get to the complete analysis.

FORBES: How to Grow an Economy